文献库搜索 | GeneLibs

Gencel-Augusto(J),Grandis(JR),Johnson(DE) Adv Biol Regul 2026-01-00

...PIK3CA, encoding the p110α catalytic subunit of PI3K enzyme, is altered in approximately 30 % of HNSCC tumors and 37 % o...

Tang(C),Wang(T),Luo(H),Xue(J),Zhu(M),Hong(... Int Urol Nephrol 2026-04-00

...PIK3CA, and TERT, and aberrant methylation in HIST1H4F, NRN1, and POU4F2. Ten machine-learning algorithms were employed ...

Kamli(H) Naunyn Schmiedebergs Arch P... 2026-02-00

...PIK3CA, MAPK1/3, HRAS), which also exhibited differential expression and prognostic relevance in lung adenocarcinoma dat...

Yu(Q),Liu(H) Front Endocrinol (Lausanne) None

...PIK3CA, and/or TP53)-were identified as the strongest independent risk factor for CLNM (odds ratio [OR] = 6.319, 95% con...

Alshehri(A),Altwairgi(AK),AlTourah(A),Alwb... Front Oncol None

...PIK3CA, AKT, BRCA, ESR1) to guide therapy, prioritizing targeted agents such as oral SERDs and PI3K/AKT inhibitors in se...

Shien(T),Nakamoto(S),Fujiwara(Y),Kosaka(M)... Cancers (Basel) 2025-07-21

...PIK3CA mutations and YAP/TAZ expression. Organ-specific strategies using stereotactic radiotherapy, surgery, and proton ...

Jia(W),Cheng(X) Biology (Basel) 2025-07-21

...PIK3CA mutations or resistance to immunotherapy, through the precise targeting of mutant PI3Kα. Compared to ATP-competit...

Kang(B),Han(B),Shen(D),Zhang(G),Zhang(X) Pathol Res Pract 2025-09-00

...PIK3CA mutation, 1 had a CCND1 mutation, 1 had a CDK6 mutation, 1 had a BCL2L11 mutation, and 1 had a non-specific molec...

Attili(I),Fabrizio(FP),Marinis(F) Cancers (Basel) 2025-07-18

...PIK3CA, RB1, and others, that significantly influence disease progression, therapeutic resistance, and clinical outcomes...

Suda(K),Takahashi(K),Tamura(R),Saito(K),Ya... Reproduction 2025-08-01

...PIK3CA (12.2%), ARID1A (12.1%), and FBXW7 (9.8%) with high mutant allele frequency. In uterine endometrial epithelium, f...